These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18632019)

  • 1. New global recommendations: a multidisciplinary approach to improving outcomes in diabetes.
    McGill M; Felton AM;
    Prim Care Diabetes; 2007 Feb; 1(1):49-55. PubMed ID: 18632019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management.
    Del Prato S; Felton AM; Munro N; Nesto R; Zimmet P; Zinman B;
    Int J Clin Pract Suppl; 2007 Dec; (157):47-57. PubMed ID: 18087796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control.
    Bailey CJ; Del Prato S; Eddy D; Zinman B;
    Int J Clin Pract; 2005 Nov; 59(11):1309-16. PubMed ID: 16236086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal.
    Del Prato S; Felton AM; Munro N; Nesto R; Zimmet P; Zinman B;
    Int J Clin Pract; 2005 Nov; 59(11):1345-55. PubMed ID: 16236091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The team approach to diabetes management: partnering with patients.
    Aschner P; LaSalle J; McGill M;
    Int J Clin Pract Suppl; 2007 Dec; (157):22-30. PubMed ID: 17991188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
    Akalin S; Berntorp K; Ceriello A; Das AK; Kilpatrick ES; Koblik T; Munichoodappa CS; Pan CY; Rosenthall W; Shestakova M; Wolnik B; Woo V; Yang WY; Yilmaz MT;
    Int J Clin Pract; 2009 Oct; 63(10):1421-5. PubMed ID: 19769698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.
    Bailey CJ; Aschner P; Del Prato S; LaSalle J; Ji L; Matthaei S;
    Diab Vasc Dis Res; 2013 Sep; 10(5):397-409. PubMed ID: 23711582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hospital pharmacist: an integral part of the hyperglycaemic management team.
    Szumita PM
    J Clin Pharm Ther; 2009 Dec; 34(6):613-21. PubMed ID: 20175794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inpatient medical rehabilitation in diabetes mellitus in light of evidence based practice guidelines: an evaluation on the basis of BfA routine data].
    Ganten JU; Raspe HH
    Rehabilitation (Stuttg); 2003 Apr; 42(2):94-108. PubMed ID: 12701002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality indicators for type-2 diabetes care in practice guidelines: an example from six European countries.
    Wens J; Dirven K; Mathieu C; Paulus D; Van Royen P;
    Prim Care Diabetes; 2007 Feb; 1(1):17-23. PubMed ID: 18632015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ; Zrebiec J
    Diabetes Metab Res Rev; 2008; 24(4):257-85. PubMed ID: 18232062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital management of type 2 diabetes mellitus.
    Lien LF; Angelyn Bethel M; Feinglos MN
    Med Clin North Am; 2004 Jul; 88(4):1085-105, xii. PubMed ID: 15308391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin and type 2 diabetes. Last resort or rational management?
    Holmwood C; Philips P
    Aust Fam Physician; 1999 May; 28(5):429-35. PubMed ID: 10376366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly.
    Vischer UM; Bauduceau B; Bourdel-Marchasson I; Blickle JF; Constans T; Fagot-Campagna A; Kaloustian E; Lassman-Vague V; Lecomte P; Simon D; Tessier D; Verny C; Doucet J;
    Diabetes Metab; 2009 Jun; 35(3):168-77. PubMed ID: 19446486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.
    IDF Clinical Guidelines Task Force
    Diabet Med; 2006 Jun; 23(6):579-93. PubMed ID: 16759299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.